Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer

Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer

Abstract Patients diagnosed with microsatellite stable (MSS) metastatic colorectal cancer (mCRC) typically have an immunosuppressive tumor microenvironment, which leads to a low response rate when treated with immunotherapy. Some studies indicate that chemotherapy and anti-angiogenic therapy could p...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhao Gao, Xiaoyan Wang, Tao Song, Shikai Wu, Xuan Jin
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Microsatellite stable
RAS mutation
Metastatic colorectal cancer
Immune checkpoint inhibitors
PD-1
Online Access:https://doi.org/10.1038/s41598-025-13701-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items